1. Home
  2. STOK vs TRNS Comparison

STOK vs TRNS Comparison

Compare STOK & TRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STOK
  • TRNS
  • Stock Information
  • Founded
  • STOK 2014
  • TRNS 1964
  • Country
  • STOK United States
  • TRNS United States
  • Employees
  • STOK N/A
  • TRNS N/A
  • Industry
  • STOK Biotechnology: Pharmaceutical Preparations
  • TRNS Electrical Products
  • Sector
  • STOK Health Care
  • TRNS Industrials
  • Exchange
  • STOK Nasdaq
  • TRNS Nasdaq
  • Market Cap
  • STOK 740.9M
  • TRNS 748.7M
  • IPO Year
  • STOK 2019
  • TRNS N/A
  • Fundamental
  • Price
  • STOK $12.87
  • TRNS $77.41
  • Analyst Decision
  • STOK Strong Buy
  • TRNS Buy
  • Analyst Count
  • STOK 5
  • TRNS 4
  • Target Price
  • STOK $27.75
  • TRNS $108.67
  • AVG Volume (30 Days)
  • STOK 763.5K
  • TRNS 76.0K
  • Earning Date
  • STOK 08-06-2025
  • TRNS 08-06-2025
  • Dividend Yield
  • STOK N/A
  • TRNS N/A
  • EPS Growth
  • STOK N/A
  • TRNS N/A
  • EPS
  • STOK 0.88
  • TRNS 1.57
  • Revenue
  • STOK $190,908,000.00
  • TRNS $278,421,000.00
  • Revenue This Year
  • STOK $378.84
  • TRNS $10.85
  • Revenue Next Year
  • STOK N/A
  • TRNS $6.52
  • P/E Ratio
  • STOK $14.68
  • TRNS $49.69
  • Revenue Growth
  • STOK 2333.81
  • TRNS 7.30
  • 52 Week Low
  • STOK $5.35
  • TRNS $67.56
  • 52 Week High
  • STOK $16.15
  • TRNS $141.27
  • Technical
  • Relative Strength Index (RSI)
  • STOK 55.63
  • TRNS 36.19
  • Support Level
  • STOK $12.25
  • TRNS $80.40
  • Resistance Level
  • STOK $14.99
  • TRNS $84.99
  • Average True Range (ATR)
  • STOK 0.83
  • TRNS 2.82
  • MACD
  • STOK -0.04
  • TRNS -0.65
  • Stochastic Oscillator
  • STOK 36.30
  • TRNS 8.25

About STOK Stoke Therapeutics Inc.

Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine. Its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to restore naturally-occurring protein levels selectively. Its first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome. The company provides early programs focused on multiple targets, including haploinsufficiency diseases of the central nervous system and eye, to up-regulate the protein expression of the underlying disease gene in a mutation-agnostic manner.

About TRNS Transcat Inc.

Transcat Inc is involved in providing calibration and laboratory instrument services and distribution of test, measurement, and control instrumentation. Its product and services portfolio consists of calibration instruments, dimensional measuring tools, Electrical test instruments, pressure measurement, etc. The firm has Service and Distribution operating segments. It derives the majority of its revenues from the Service segment. The firm promotes and sells its products under brand names such as Estech, FLIR, Fluke, Keysight, and Megger among others. It serves to pharmaceutical, industrial manufacturing, energy, and chemical process industries.

Share on Social Networks: